Q&A: Lundbeck’s head of R&D on letting ‘biology speak’ in neuroscience

Max Gelman

Senior Editor

Johan Luthman has been running R&D at Lundbeck since 2019, and part of the neuroscience leader’s remit is helping steer development of a promising but …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Q&A: Lundbeck’s head of R&D on letting ‘biology speak’ in neuroscience

Max Gelman

Senior Editor

Sign up to read this article for free.

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

Market turmoil is tanking biotech M&A and IPOs. Here's the playbook startups will use to survive

Makary wants to replace animal testing with organoids. It may take a while

Recruiters say some biopharmas pause hiring as they struggle to make sense of ongoing uncertainty

Exclusive: Merida Biosciences gets $121M to treat autoimmune and allergy diseases at their roots

Pharma tariffs: Here’s what a potential rollout could look like

Bristol Myers' immunotherapy combo nets approvals in colorectal and liver cancer

Q&A: Lund­beck’s head of R&D on let­ting ‘bi­ol­o­gy speak’ in neu­ro­science

Senior Editor

Sign up to read this article for free.

more like this

Gondolabio

Palo Alto, CA, USA

Q&A: Lundbeck’s head of R&D on letting ‘biology speak’ in neuroscience